NovaBridge Biosciences (NBP) Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Intangibles for 6 consecutive years, with $16.4 million the latest figure, recorded in Q4 2023.

• Quarterly Intangibles fell 1.87% year-over-year to $16.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.4 million (down 1.87% YoY) and the FY2023 annual result came in at $16.7 million, down 99.9% from the prior year.
• Intangibles steadied at $16.4 million in Q4 2023 per NBP's latest filing, from $16.3 million in the prior quarter.
• Over the last five years, Intangibles for NBP reached as high as $18.7 billion in Q4 2021 and fell as low as $16.3 million in Q2 2023.
• A 5-year average of $1.9 billion and a median of $18.1 million in 2020 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2021 — Intangibles surged 102886.2% — and 2022, when it tumbled 99.91%.
• Year by year, Intangibles stood at $21.1 million in 2019, then declined by 13.94% to $18.2 million in 2020, then jumped by 102886.2% to $18.7 billion in 2021, then slumped by 99.91% to $16.7 million in 2022, then fell by 1.87% to $16.4 million in 2023.
• According to Business Quant data, Intangibles over the past three periods registered $16.4 million, $16.3 million, and $16.7 million for Q4 2023, Q2 2023, and Q4 2022 respectively.